Loading clinical trials...
Loading clinical trials...
This clinical trial is designed to study the effects of rifampicin on the glucose, lipid and hormone homeostasis in healthy volunteers. The main hypothesis is that rifampicin lowers fasting glucose an...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
University of Oulu
NCT07286747 · Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)
NCT07440147 · Obesity & Overweight, Circadian Rhythm Disorders, and more
NCT05441982 · Continuous Glucose Monitoring, Oral Glucose Tolerance, and more
NCT06964620 · Diabetes Mellitus, Type 2, Impaired Glucose Tolerance
NCT05300256 · Glucose Tolerance
Oulu University Hospital
Oulu
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions